6509--Warfarin Tablets (VA-25-00012328)

The Department of Veterans Affairs National Acquisition Center is seeking a contractor to supply Warfarin sodium tablets in nine different strengths ranging from 1mg to 10mg, with packaging options of 100 and 1000 tablets per bottle. The solicitation aims to establish a contract that will serve VA, Department of Defense, Indian Health Service, and Bureau of Prisons facilities through their Pharmaceutical Prime Vendor programs. Manufacturers must maintain current Good Manufacturing Practice status with the FDA and provide tablets that match the reference drug Coumadin's colors and embossing requirements. Offerors are required to submit comprehensive pricing for a base year and four optional years, include a 0.5% Cost Recovery Fee, provide color sheets of tablets, and submit unique 11-digit NDC numbers. The original proposal deadline was December 17, 2024, but Amendment 0001 extended the submission date to December 31, 2024, at 2:30 PM CST, with electronic submissions required.

The contract is an unrestricted solicitation in the Pharmaceutical Preparation Manufacturing (NAICS 325412) category, with one aggregate award planned for all 16 line items. The implementation period is limited to a maximum of 60 days following contract award, with order fulfillment beginning after successful implementation. While specific award values are not detailed, the contract will cover multiple federal agencies and includes provisions for a base year plus four one-year option periods. The place of performance is not explicitly stated, but the solicitation is managed by the VA National Acquisition Center in Hines, Illinois. Contractors must be prepared to provide high-quality Warfarin tablets that meet strict color, marking, and packaging specifications, with the ability to serve multiple federal healthcare systems simultaneously.